EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prognostic value of chemotherapy-related mean corpuscular hemoglobin (MCH) kinetics in patients with non-small cell lung cancer receiving adjuvant chemotherapy

Jiaxin Cao, Qun Chen, Ting Yang, Kangmei Zeng, Yan Huang, Yuxiang Ma, Hongyun Zhao, Fan Luo

Cancer Treatment and Research Communications · 2026

DOI: 10.1016/j.ctarc.2026.101223 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Jiaxin Cao und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Cli…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Erythrocyte Indices, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Sun Yat-sen University, Chinese Society of Clinical Oncology, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The relationship of nutrition-related indexes kinetics and the survival in patients with non-small cell lung cancer (NSCLC) receiving adjuvant chemotherapy is unclear. To investigate the association between changes in nutritional indices at 4 weeks after completion of adjuvant chemotherapy and disease-free survival (DFS) in patients with completely resected NSCLC. METHODS: The 195 patients with NSCLC who accepted radical surgery and postoperative chemotherapy were identified in this retrospective single-center cohort study. Longitudinal blood samples were collected before and after adjuvant chemotherapy to measure nine nutritional indexes, including red blood cell (RBC), hemoglobin (HGB), mean corpuscular volume (MCV), hematocrit (HCT), mean corpuscular hemoglobin (MCH), total protein (TP), albumin (ALB), globulin (GLOB), and albumin to globulin ratio (AGR). Cox proportional hazards regression models were used to analyze the prognostic factors for DFS. RESULTS: There were significant variations in HGB, MCV, HCT and MCH in post-adjuvant chemotherapy patients with NSCLC. Lower baseline HGB and HCT were associated with unfavorable DFS. Besides, patients with decreasing MCV and MCH at 4 weeks after adjuvant chemotherapy exhibited superior DFS. Univariate and multivariate analyses identified the chemotherapy-related MCH reduction (HR=0.502, 95% CI:0.287-0.877, P = 0.015) as an independent prognostic factor associated with favorable DFS. CONCLUSION: MCH reduction at 4 weeks after adjuvant chemotherapy was associated with improved DFS in NSCLC patients receiving adjuvant chemotherapy. This exploratory finding is hypothesis-generating and requires validation in larger, multicenter prospective studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsErythrocyte IndicesAntineoplastic Combined Chemotherapy ProtocolsHumansChemotherapy, AdjuvantFemalePrognosisMaleRetrospective StudiesMiddle AgedAgedDisease-Free SurvivalAdult

Stichwörter der Autor:innen

Adjuvant chemotherapyMCHNon-small cell lung cancerNutrition-related indicatorsPrognosis

Autor:innen und Institutionen

  • State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center…
  • Fujian Medical University Union Hospital, Fuzhou, 350000, PR China.

Förderung

  • Sun Yat-sen University
  • Chinese Society of Clinical Oncology
  • National Natural Science Foundation of China
  • Sun Yat-sen University Cancer Center
  • Fundamental Research Funds for the Central Universities
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Cao, J., Chen, Q., Yang, T., Zeng, K., Huang, Y., Ma, Y., Zhao, H., & Luo, F. (2026). Prognostic value of chemotherapy-related mean corpuscular hemoglobin (MCH) kinetics in patients with non-small cell lung cancer receiving adjuvant chemotherapy. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2026.101223

Vancouver

Cao J, Chen Q, Yang T, Zeng K, Huang Y, Ma Y, et al. Prognostic value of chemotherapy-related mean corpuscular hemoglobin (MCH) kinetics in patients with non-small cell lung cancer receiving adjuvant chemotherapy. Cancer Treatment and Research Communications. 2026. doi:10.1016/j.ctarc.2026.101223

BibTeX
@article{Cao2026,
  author = {Cao, Jiaxin and Chen, Qun and Yang, Ting and Zeng, Kangmei and Huang, Yan and Ma, Yuxiang and Zhao, Hongyun and Luo, Fan},
  title = {Prognostic value of chemotherapy-related mean corpuscular hemoglobin (MCH) kinetics in patients with non-small cell lung cancer receiving adjuvant chemotherapy},
  journal = {Cancer Treatment and Research Communications},
  year = {2026},
  doi = {10.1016/j.ctarc.2026.101223}
}
Kostenlos starten →